Skip to main content
Subscribe
Log In
More
Log in via Institution
Log in via OpenAthens
Log in via your Society
Select your society
ASRA
ESRA
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Current issue
Archive
Authors
About
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Current issue
Archive
Authors
About
Subscribe
Log in
More
Log in via Institution
Log in via OpenAthens
Log in via your Society
Select your society
ASRA
ESRA
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
Refractory pain
Email alerts
Refractory pain
Comparison of 0.5% Intrathecal Bupivacaine With 0.5% Intrathecal Ropivacaine in the Treatment of Refractory Cancer and Noncancer Pain Conditions: Results From a Prospective, Crossover, Double-Blind, Randomized Study
Peter
Dahm
,
Christopher
Lundborg
,
Magnus
Janson
,
Cecilia
Olegård
,
Petre
Nitescu
Regional Anesthesia & Pain Medicine
Sep 2000,
25
(5)
480-487;
DOI:
10.1053/rapm.2000.8574
Special collections
Editor's choice
(60)
Guidelines, Recommendations and Consensus Statements
Open access
(176)
Press releases
(20)
